Albert Garcia-Romeu

Associate Professor at Johns Hopkins University School of Medicine

Data updated

Papers

30 publications

Trials

0 clinical trials

Research Footprint

Albert Garcia-Romeu appears in 30 tracked papers (2014–2026), most studied alongside Psilocybin, LSD and Ketamine, across Substance Use Disorders (SUD), Depressive Disorders and Anxiety Disorders.

Most-cited paper: Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction (899 citations).

Frequent co-authors: Matthew Johnson, Roland Griffiths and Sandeep Nayak.

Background & Research

Dr. Albert Garcia-Romeu is a psychologist at the Johns Hopkins Center for Psychedelic and Consciousness Research. His research focuses on the clinical applications of psilocybin, particularly for smoking cessation and alcohol use disorder. He also explores the relationship between self-transcendence, spiritual experiences, and long-term improvements in mental health and well-being.

Key Impact

Leading researcher on the use of psilocybin for addiction and the role of spirituality in mental health.

30

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

20 collaborators· click a node to visit their profile

Full network →

Compounds

PsilocybinLSDKetamineMDMAEsketamine

Topics

Substance Use Disorders (SUD)Depressive DisordersAnxiety DisordersTobacco/Nicotine Use Disorder (TUD)Healthy VolunteersPublic Health, Prevention & Behaviour ChangeAlcohol Use Disorder (AUD)AdolescentsSet & SettingPersonality & Trait FactorsPalliative & End-of-Life DistressEquity and EthicsSafety & Risk ManagementImmunology & InflammationCreativityPTSDMajor Depressive Disorder (MDD)Opioid Use Disorder (OUD)Chronic PainHeadache Disorders (Cluster & Migraine)Implementation & Service DeliverySuicidalityBipolar DisorderInterpersonal Functioning & Social ConnectednessNeurocognitive DisordersNeuroimaging & Brain MeasuresTreatment-Resistant Depression (TRD)Older Adults

Top Collaborators

Affiliations

Institutions, companies, and organisations Albert Garcia-Romeu is associated with.

Johns Hopkins University

academic

The Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.

View stakeholder →

Johns Hopkins Center for Psychedelic and Consciousness Research

A research center within Johns Hopkins University (School of Medicine) that conducts scientific studies on psychedelic compounds, their effects on brain function and consciousness, and their therapeutic potential for mental health conditions.

View stakeholder →